Deine Themen. Neue Beiträge.

Eine kompakte Browser-Benachrichtigung, wenn es Neues gibt. Höchstens einmal am Tag – auch ohne Konto.

Was interessiert dich?

Freiwillig und jederzeit hier abschaltbar. Themenauswahl und Geräte-Abonnement werden gespeichert; eine E-Mail-Adresse ist nicht nötig. Datenschutz

Den Harbor durchsuchenEN/DEKonto
Mediathek· RobertLufkinMDAudio: Englisch (Vereinigte Staaten)

The Alzheimer's Lie: It's Not Amyloid | David Perlmutter MD

Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.

Verlauf & EmpfehlungenAus

Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.

Bis zu 120 Einträge · 90 Tage. Ausschalten löscht den Verlauf.
Merkliste & Verlauf öffnen →

Über dieses Video

Creator-Beschreibung · OriginaltextTextsprache: Englisch

Neurologist David Perlmutter MD says the beta-amyloid theory of Alzheimer's is wrong — and the real culprit is your brain's own immune cells. Here's the science. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with renowned neurologist and #1 New York Times bestselling author David Perlmutter MD to unpack his new book Brain Defenders. They explore microglia — the brain's immune cells — and how diet, blood sugar, and metabolic health flip these cells from protective ("M2") to destructive ("M1"), driving Alzheimer's, Parkinson's, and other neurodegenerative disease. Perlmutter explains why anti-amyloid drugs offer "trivial" benefit at serious risk, which biomarkers actually predict your brain's future, and what you can start doing today. CHAPTERS: 00:00 — Introduction 01:38 — Why He Left Mainstream Neurology to Prevent Brain Decline 05:24 — Building the World's Largest Integrative Neurology Practice 06:55 — The Common Pathway From Metabolism to Brain Degeneration 08:25 — Why the Beta-Amyloid Theory of Alzheimer's Is Wrong 09:11 — What Are Microglia? The Brain's Immune Cells (M1 vs M2) 12:13 — From Brain "Glue" to Master Regulators of Your Synapses 16:00 — How Body Inflammation and Cytokines Reach the Brain 18:15 — Leaky Gut, the Microbiome, and Brain Degeneration 19:46 — Ultra-Processed Foods Raise Alzheimer's Risk Up to 270% 25:02 — Synaptic Pruning: The Link Between Autism, ADHD and Alzheimer's 29:36 — Why Diabetics Recover Worse From Head Trauma 31:51 — Anti-Amyloid Drugs: "Trivial" Benefit, Serious Harm 35:37 — The Biomarkers to Track: Fasting Glucose, Insulin, A1C 40:09 — On the Horizon: Mitochondrial Therapies and Microglial Transplants 45:26 — Glyphosate, Air Pollution and 40Hz Light Therapy 47:00 — Brain Defenders Releases August 18 — Final Takeaways KEY TAKEAWAYS: • Alzheimer's is increasingly understood as a "synaptopathy" — a disease of lost synapses driven by the brain's own immune cells (microglia), not simply a buildup of beta-amyloid plaque. • Microglia shift from supportive (M2) to destructive (M1) in response to metabolic signals: high blood sugar, insulin resistance, elevated blood pressure, excess body fat, and inflammation. • A long-term cohort found each daily serving of ultra-processed food raised Alzheimer's risk ~13%, with 10+ servings/day linked to a 2.7-fold (270%) increase — and ultra-processed foods make up ~60% of U.S. adult calories. • A Cochrane review of anti-amyloid antibodies found "trivial" cognitive benefit alongside meaningful harm, including brain swelling and microbleeds (ARIA) in a substantial share of patients. • The most actionable brain biomarkers are cheap and accessible: fasting blood glucose, fasting insulin, hemoglobin A1c, waist circumference, and a continuous glucose monitor — aim for optimal, not just "normal." • Emerging frontiers target the mitochondria inside microglia — metformin, CoQ10, urolithin A, exercise, fasting, ketones, and experimental approaches like 40Hz gamma light therapy. STUDIES & SOURCES MENTIONED: • Weinstein et al., J Prev Alzheimers Dis — ultra-processed food and Alzheimer's risk (1,375 participants, ~12.7 years; 13% per serving, 2.7-fold at 10+ servings/day) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12184002/ • Cochrane Review (2026) — anti-amyloid monoclonal antibodies for Alzheimer's: little-to-no cognitive benefit, increased brain swelling and microbleeds — https://www.cochrane.org/evidence/CD016297_are-medicines-anti-amyloid-monoclonal-antibodies-reduce-build-abnormal-proteins-brain-effective • Iaccarino, Tsai et al. (Tsai Lab, MIT) — 40Hz gamma light flicker recruits microglia and reduces amyloid — https://pubmed.ncbi.nlm.nih.gov/30072722/ ───────────────────────────────── 🔔 Subscribe for more evidence-based health insights 📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Substack newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com #brainhealth #alzheimers #davidperlmutter #robertlufkinmd #healthlongevity

RobertLufkinMD · 49 min · Quelle veröffentlicht: 2026-08-31

Zu Harbor hinzugefügt: 23.10.2026

Original auf YouTube ↗

Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.

Diskussion

Community-Diskussionen

0 Themen

Mitgliederbeiträge. Quellen nennen, kommerzielle Interessen offenlegen und keine persönliche medizinische Beratung oder Dosierungsempfehlungen geben.

Wird geladen…